Dotmatics Vision for a Healthier Future
In a recent NBC North Carolina news feature, Alister Campbell, VP of Global Science and Technology at Dotmatics, discussed the transformative impact of artificial intelligence (AI) on the field of medicine. AI is not a new concept in science, but recent technological advancements have ushered in a new era of possibilities for healthcare.
Alister explained that AI has enabled scientists to harness the vast amounts of data collected from clinical studies more effectively. This, in turn, has expedited medical discoveries. Notably, AI has played a crucial role in expediting the development of new therapies, with 15 different treatments currently in clinical trials.
The discussion also touched upon the potential risks and benefits of accelerating technology in healthcare. Alister emphasized the importance of maintaining a focus on generating high-quality data and using it to build trustworthy AI models. This approach can significantly reduce the time and cost associated with drug development, ultimately benefiting patients and the industry.
As a leading player in this field, Dotmatics is actively supporting researchers in their quest to accelerate medical discoveries. With a global network of over 10,000 research organizations and 2 million scientists using their products, Dotmatics is poised to contribute significantly to the advancement of healthcare through AI.
Learn More About Dotmatics
Meet with a product expert to see how Dotmatics uses AI technologies to drive down the cost of drug discovery.